COO Cooper Companies (The)
Data as of close
Cooper Companies (The) (COO) is a healthcare company in the Ophthalmic Goods industry, with a market capitalization of $11.7 billion. Shares last traded at $61.30, 30.9% below their 52-week high. Over the past year the stock is down 12.6%. COO trades at a price-to-earnings ratio of 20.44, below the Ophthalmic Goods median of 176.40. Net profit margin is 13.5%, above the peer median of 1.0%. Revenue grew 5.1% year over year.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. COO split history →
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-07-31. Source: SEC EDGAR/XBRL.
COO Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2023-10-31 | $3M | $0.02 | 1% |
| 2022-10-31 | $3M | $0.02 | 1% |
| 2021-10-31 | $3M | $0.06 | 0% |
| 2020-10-31 | $3M | $0.06 | 1% |
| 2019-10-31 | $3M | $0.06 | 1% |
| 2018-10-31 | $3M | $0.06 | 2% |
| 2017-10-31 | $3M | $0.06 | 1% |
| 2016-10-31 | $3M | $0.06 | 1% |
| 2015-10-31 | $3M | $0.06 | 1% |
| 2014-10-31 | $3M | $0.06 | 1% |
| 2013-10-31 | $3M | $0.06 | 1% |
| 2012-10-31 | $3M | $0.06 | 1% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q3 2026 | $2.24 | 2026-09-09 |
| Q2 2026 | -$0.40 | 2026-06-05 |
| Q1 2026 | $0.66 | 2026-03-06 |
| Q4 2025 (derived) | $0.42 | 2025-12-05 |
| FY 2025 | $1.87 | 2025-12-05 |
| Q3 2025 | $0.49 | 2025-08-28 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
Ophthalmic Goods peers
COO vs 9 industry peers (Ophthalmic Goods), by market cap. Data as of close
| ALC | Alcon Inc | $35.9B | — | — | — | +2.97% |
| COO | Cooper Companies (The) | $11.7B | 20.44 | 2.75 | 13.5% | +2.97% |
| BLCO | Bausch & Lomb Corp | $7.2B | — | 1.32 | -2.0% | +0.18% |
| WRBY | Warby Parker Inc. | $2.9B | 380.79 | 3.23 | 0.8% | -3.07% |
| EYE | National Vision Holdings, Inc. | $1.4B | 26.97 | 0.67 | 2.5% | +3.38% |
| STAA | Staar Surgical Co | $1.3B | 325.82 | 3.68 | 1.1% | +1.61% |
| RXST | Rxsight, Inc. | $200M | — | 1.65 | -38.8% | -1.13% |
| LUCY | Innovative Eyewear Inc | $7M | — | — | — | +1.33% |
| LUCYW | Innovative Eyewear Inc | — | — | — | — | +3.93% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.